115 related articles for article (PubMed ID: 1798729)
1. [The pharmacokinetics of Oral-Turinabol in humans].
Schumann W
Pharmazie; 1991 Sep; 46(9):650-4. PubMed ID: 1798729
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
Kopitar Z; Zimmer A
Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
[TBL] [Abstract][Full Text] [Related]
7. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
[TBL] [Abstract][Full Text] [Related]
8. Metabolism, kinetics and metabolic activity of the beta-cytotropic antidiabetic 4-(5-isobutylpyrimidinyl-2)-sulphamylphenylacetic acid-3-chloro-6-methoxyanilide sodium (glydanile sodium) in man after oral and intravenous administration.
Gerhards E; Berger D; Peters S
Arzneimittelforschung; 1976 Feb; 26(2):278-86. PubMed ID: 947213
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of glucosamine in man.
Setnikar I; Palumbo R; Canali S; Zanolo G
Arzneimittelforschung; 1993 Oct; 43(10):1109-13. PubMed ID: 8267678
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
13. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
Kreis W; Gordon CS; DeJager R; Krakoff IH
Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
[TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
16. [Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)].
Adlung J; Höhle KD; Zeren S; Wahl D
Arzneimittelforschung; 1976; 26(5a):1005-10. PubMed ID: 134721
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
Mierau J
Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
19. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs.
Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O
Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259
[TBL] [Abstract][Full Text] [Related]
20. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]